Literature DB >> 19727589

Comparison and significance of specific and non-specific cellular immunity in patients with chronic hepatitis B caused by infection with genotypes B or C of hepatitis B virus.

XiBing Gu1, XiaoJuan Yang, Dong Wang, Zhong Hua, HangYuan Wu, HaoKun Chen, YueQin Xu, ZhongHua Lu.   

Abstract

The present study was designed to investigate possible relationships between the genotypes of hepatitis B virus (HBV) and the HBV-specific cytotoxic T lymphocyte (CTL) responses. HBV genotypes, HBV specific CTL HBV DNA and other markers of HBV infection were determined in 138 patients with chronic hepatitis B. The results showed that the patients infected with genotype C (n=62) had a significantly lower HBV-specific CTL response than those who were infected with HBV genotype B (P<0.01). HBV DNA titer was higher in patients infected with HBV genotype C than in those infected with HBV genotype B (P<0.01). Both alanine aminotransferase (ALT) and total bilirubin (TBIL) were higher in HBV genotype C infected patients than in those infected with genotype B (P<0.01 and <0.05, respectively). These results suggest that compared with CHB patients infected with HBV genotype B, the higher HBV DNA level and more severe liver damages in the patients infected with genotype C of HBV may be associated with genotype C of the virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727589     DOI: 10.1007/s11427-009-0098-0

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  6 in total

1.  Solely HBsAg intrauterine exposure accelerates HBV clearance by promoting HBs-specific immune response in the mouse pups.

Authors:  Jing Ning; Jianwen Wang; Huiling Zheng; Siwen Peng; Tianhao Mao; Lu Wang; Guangxin Yu; Jia Liu; Shuang Liu; Ting Zhang; Shigang Ding; Fengmin Lu; Xiangmei Chen
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

2.  Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance.

Authors:  Gu Xibing; Yang Xiaojuan; Lu Zhonghua; Wang Juanhua
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

3.  Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment.

Authors:  Renyong Guo; Hejun Mao; Xiao Hu; Nengneng Zheng; Dong Yan; Jianqin He; Jiezuan Yang
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

4.  Translational medicine in China I: perspectives from Chinese physicians and scientists.

Authors:  Chengyu Jiang
Journal:  Sci China Life Sci       Date:  2012-01-07       Impact factor: 6.038

5.  CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice.

Authors:  Daniel Stone; Kelly R Long; Michelle A Loprieno; Harshana S De Silva Feelixge; Elizabeth J Kenkel; R Matt Liley; Stephen Rapp; Pavitra Roychoudhury; Thuy Nguyen; Laurence Stensland; Rossana Colón-Thillet; Lindsay M Klouser; Nicholas D Weber; Connie Le; Jessica Wagoner; Erin A Goecker; Alvason Zhenhua Li; Karsten Eichholz; Lawrence Corey; D Lorne Tyrrell; Alexander L Greninger; Meei-Li Huang; Stephen J Polyak; Martine Aubert; John E Sagartz; Keith R Jerome
Journal:  Mol Ther Methods Clin Dev       Date:  2020-11-26       Impact factor: 6.698

6.  Relationship between HBV genotypes B, C and follicular helper T cells in patients with chronic hepatitis B and its significance.

Authors:  Gu Xibing; Yang Xiaojuan; Wang Juanhua; Hua Zhong
Journal:  Hepat Mon       Date:  2013-01-20       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.